The regulation of cellular bioenergetics is recognised as a key driver of cancer cell proliferation. Identifying key pathways that modulate bioenergetic metabolism is a promising strategy for developing novel therapeutics for cancer treatment.
In this App Note you will learn:
- How the Agilent Seahorse XF Real Time ATP rate assay provides a simple robust workflow that can identify metabolic targets for drug discovery.
- How it can identify metabolic target pathways to be investigated during cancer drug discovery.
- About the dedicated analytic software as a direct way to quantitate and compare the metabolic response of cancer cells to chemicals or genetic modification and differentiate mitochondrial and glycolytic energetic metabolism.
Brought to you by
![Agilent_Logo_RGB-1](https://info.edifydigitalmedia.com/hs-fs/hubfs/Agilent_Logo_RGB-1.png?width=146&height=59&name=Agilent_Logo_RGB-1.png)